105 related articles for article (PubMed ID: 16334395)
1. [Changes of edema associated with I-125 prostate brachytherapy].
Aoki M; Miki K; Takahashi H; Takagi S; Fukuda I; Honda C; Kobayashi M; Egawa S; Kanehira C
Nihon Igaku Hoshasen Gakkai Zasshi; 2005 Oct; 65(4):411-8. PubMed ID: 16334395
[TBL] [Abstract][Full Text] [Related]
2. Effect of edema on postimplant dosimetry in prostate brachytherapy using CT/MRI fusion.
Tanaka O; Hayashi S; Matsuo M; Nakano M; Uno H; Ohtakara K; Miyoshi T; Deguchi T; Hoshi H
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):614-8. PubMed ID: 17869675
[TBL] [Abstract][Full Text] [Related]
3. Effect of post-implant edema on prostate brachytherapy treatment margins.
Reed DR; Wallner K; Ford E; Mueller A; Merrick G; Maki J; Sutlief S; Butler W
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1469-73. PubMed ID: 16137839
[TBL] [Abstract][Full Text] [Related]
4. Impact of intraoperative edema during transperineal permanent prostate brachytherapy on computer-optimized and preimplant planning techniques.
Yamada Y; Potters L; Zaider M; Cohen G; Venkatraman E; Zelefsky MJ
Am J Clin Oncol; 2003 Oct; 26(5):e130-5. PubMed ID: 14528087
[TBL] [Abstract][Full Text] [Related]
5. [Physical basics and clinical realization of interstitial brachytherapy of the prostate with iodine 125].
Kaulich TW; Lamprecht U; Paulsen F; Kahmann F; Maurer U; Henkel TO; Loeser W; Bichler KH; Nüsslin F; Bamberg M
Strahlenther Onkol; 2002 Oct; 178(10):548-55. PubMed ID: 12386786
[TBL] [Abstract][Full Text] [Related]
6. Timing of computed tomography-based postimplant assessment following permanent transperineal prostate brachytherapy.
Prestidge BR; Bice WS; Kiefer EJ; Prete JJ
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1111-5. PubMed ID: 9539566
[TBL] [Abstract][Full Text] [Related]
7. Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.
Dicker AP; Lin CC; Leeper DB; Waterman FM
Semin Urol Oncol; 2000 May; 18(2):152-9. PubMed ID: 10875458
[TBL] [Abstract][Full Text] [Related]
8. Dose-volume conundrum for response of prostate cancer to brachytherapy: summary dosimetric measures and their relationship to tumor control probability.
D'Souza WD; Thames HD; Kuban DA
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1540-8. PubMed ID: 15050335
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
[TBL] [Abstract][Full Text] [Related]
10. Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry.
Van Gellekom MP; Moerland MA; Van Vulpen M; Wijrdeman HK; Battermann JJ
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):772-80. PubMed ID: 15964707
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent changes in CT-based dosimetry of I-125 prostate brachytherapy.
Willins J; Wallner K
Radiat Oncol Investig; 1998; 6(4):157-60. PubMed ID: 9727874
[TBL] [Abstract][Full Text] [Related]
12. Time course of prostatic edema post permanent seed implant determined by magnetic resonance imaging.
Sloboda RS; Usmani N; Pedersen J; Murtha A; Pervez N; Yee D
Brachytherapy; 2010; 9(4):354-61. PubMed ID: 20116344
[TBL] [Abstract][Full Text] [Related]
13. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
Pickett B; Pouliot J
Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917
[TBL] [Abstract][Full Text] [Related]
14. Technical acquisition and dosimetric assessment of iodine-125 permanent brachytherapy in localized prostate cancer: our first series of 100 patients.
Tanaka N; Asakawa I; Kondo H; Tanaka M; Fujimoto K; Hasegawa M; Konishi N; Hirao Y
Int J Urol; 2009 Jan; 16(1):70-4. PubMed ID: 19120529
[TBL] [Abstract][Full Text] [Related]
15. A nomogram to compensate for intraoperative prostate edema during transperineal brachytherapy.
Potters L; Wang XH; Yamada Y
Tech Urol; 2000 Jun; 6(2):99-103. PubMed ID: 10798808
[TBL] [Abstract][Full Text] [Related]
16. [Histological follow-up after implantation of grains of I-125 for prostatic cancer].
Nadalini VF; Giglio C; Bruttini G; Positano N; Fassone M; Fasce L; Medica M; de Angelis P; Fantacci O; Scarpati D; Ledda S
J Urol (Paris); 1983; 89(3):187-190. PubMed ID: 6875299
[TBL] [Abstract][Full Text] [Related]
17. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M
Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108
[TBL] [Abstract][Full Text] [Related]
18. 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view.
Nickers P; Thissen B; Jansen N; Deneufbourg JM
Radiother Oncol; 2006 Jan; 78(1):47-52. PubMed ID: 16216365
[TBL] [Abstract][Full Text] [Related]
19. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
20. Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy.
Mabjeesh NJ; Chen J; Stenger A; Matzkin H
Urology; 2007 Sep; 70(3):548-53. PubMed ID: 17905113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
